BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Nov 30, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-11-28

Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-28	Common Stock	M	2500	$14.39	Acquired	13070	Direct
2012-11-28	Common Stock	M	916	$17.86	Acquired	13986	Direct
2012-11-28	Common Stock	M	2500	$21.51	Acquired	16486	Direct
2012-11-28	Common Stock	S	5916	$48.3125	Acquired	10570	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-28	Stock Option (right to buy) Common Stock	$14.39	M	2500	Disposed	2019-05-11	Common Stock (2500)	Direct
2012-11-28	Stock Option (right to buy) Common Stock	$17.86	M	916	Disposed	2018-12-16	Common Stock (916)	Direct
2012-11-28	Stock Option (right to buy) Common Stock	$21.51	M	2500	Disposed	2020-05-11	Common Stock (2500)	Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $48.373 to $48.34. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Original option grant vests 6/48th on November 12, 2009 and 1/48th on the 12th of each month thereafter.

F3: Original option grant vests 6/48th on May 17, 2009 and 1/48th on the 17th of each month thereafter.

F4: Original option grant vests 6/48th on November 12, 2010 and 1/48th on the 12th of each month thereafter.